Home/Pipeline/ViaLuxe Laser System (FLigHT Procedure)

ViaLuxe Laser System (FLigHT Procedure)

Open-angle glaucoma

RegulatoryActive

Key Facts

Indication
Open-angle glaucoma
Phase
Regulatory
Status
Active
Company

About ViaLase

ViaLase is a clinical-stage ophthalmic device company developing the ViaLuxe Laser System for the noninvasive treatment of open-angle glaucoma. The company's FLigHT procedure utilizes femtosecond laser technology and proprietary imaging to perform a standalone, non-incisional intervention, positioning it as a potential disruptor between ineffective medications and invasive surgeries. With its products not yet for sale pending regulatory clearance, ViaLase is targeting a significant unmet need in a large, chronic disease market dominated by treatments with compliance, efficacy, and safety limitations.

View full company profile

Therapeutic Areas

Other Open-angle glaucoma Drugs

DrugCompanyPhase
VisiPlateAvisiPivotal Trial
MINIject®iSTAR MedicalPivotal Trial (US) / Post-Market (EU)